di Reumatologia, Società Italiana, trans. 2026. “PO:08:119 | Infusional Advantage: Rituximab’s Role in Enhancing Adherence in Multimorbid Rheumatoid Arthritis: Marco Capodiferro1, Daniele Domanico1, Angelica Napoletano1, Giulia Righetti2, Patrizia Suppressa2, Vincenzo Venerito1, Giuseppe Lopalco1, Florenzo Iannone1, Fabio Cacciapaglia1|2 | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area DiMePRe-J University of Bari, Italy; 2Department of Medicine and Surgery, Miulli General Hospital Acquaviva Delle Fonti - LUM University Casamassima Bari Acquaviva Delle Fonti, Bari, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2307.